Vanguard Group Inc Atri Cure, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,659,781 shares of ATRC stock, worth $143 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,659,781
Previous 4,621,933
0.82%
Holding current value
$143 Million
Previous $105 Million
24.15%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Black Rock Inc. New York, NY4.62MShares$142 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$122 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$87 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$85.7 Million0.5% of portfolio
-
Macquarie Group LTD Australia, C32.38MShares$73.3 Million0.07% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.43B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...